IP Library Granted Patent US 8,945,850
Granted Patent B2
US 8,945,850 · App. 12/105,380 · Granted Feb 3, 2015

Detection, identification and differentiation of

Inventors: Sofie Claeys (Brugge-Sint-Kruis, BE); Geert Jannes (Leuven, BE); Gerd Haberhausen (Penzberg, DE); Thomas Emrich (Iffeldorf, DE); Lia Verdoodt (De Pinte, BE)
Assignees: Fujirebio Europe N.V.; Roche Diagnostics GmbH
C12Q1/689
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,945,850
App. No.
12/105,380
Granted
Feb 3, 2015
Kind
B2
Abstract

The present invention relates to a method for the specific detection and/or identification of Staphylococcus species, in particular Staphylococcus aureus , using new nucleic acid sequences derived from the ITS (Internal Transcribed Spacer) region. The present invention relates also to said new nucleic acid sequences derived from the ITS region, between the 16S and 23S ribosomal ribonucleic acid (rRNA) or rRNA genes, to be used for the specific detection and/or identification of Staphylococcus species, in particular of S. aureus , in a biological sample. It relates also to nucleic acid primers to be used for the amplification of said spacer region of Staphylococcus species in a sample.

Claims (23)

1. A method for the detection and/or identification of Staphylococcus aureus in a sample, comprising the steps of

(i) hybridizing the polynucleic acids of the sample with at least two polynucleotide probes that hybridize to a target sequence within 25 nucleotides of each other, wherein the at least two polynucleotide probes are SEQ ID NO:17 and SEQ ID NO:19, and wherein the target sequence comprises at least 50 consecutive nucleotides from a nucleic acid molecule of

SEQ ID NO:1 or

SEQ ID NO: 2 or

a Staphylococcus aureus sequence homologous to SEQ ID NO:1, or

a Staphylococcus aureus sequence homologous to SEQ ID NO: 2, or

the RNA form of SEQ ID NO: 1 wherein T is replaced by U, or

the RNA form of SEQ ID NO 2 wherein T is replaced by U, or

the RNA form of said Staphylococcus aureus specific homologue of SEQ ID NO: 1 wherein T is replaced by U, or

the RNA form of said Staphylococcus aureus specific homologue of SEQ ID NO: 2 wherein T is replaced by U, or

the sequence complementary to SEQ ID NO:1

the sequence complementary to SEQ ID NO:2

the sequence complementary to the Staphylococcus aureus sequence homologous to SEQ ID NO:1, or

the sequence complementary to the Staphylococcus aureus sequence homologous to SEQ ID NO:2, or

the sequence complementary to the RNA form of said SEQ ID NO:1 wherein T is replaced by U, or

the sequence complementary to the RNA form of said SEQ ID NO:2 wherein T is replaced by U, or

the sequence complementary to the RNA form of said Staphylococcus aureus sequence homologous to SEQ ID NO: 1 wherein T is replaced by U,

the sequence complementary to the RNA form of said Staphylococcus aureus sequence homologous to SEQ ID NO:2 wherein T is replaced by U,

(ii) detecting the hybrids formed as a result of (i), and

(iii) detecting or identifying Staphylococcus aureus in the sample based on the presence of the hybrids detected in (ii)

wherein the method comprises the step of amplifying the 16S-23S rRNA spacer region, or a fragment comprising the target sequence, or the target sequence in a PCR amplification preceding step (i),

wherein the PCR amplification comprises the use of the primers of SEQ ID NO:68 and SEQ ID NO:58.

2. A method according to claim 1 , wherein the method comprises the step of releasing, isolating and/or concentrating the polynucleic acids in the sample preceding the PCR amplification.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2014
From: CLAEYS, SOFIE; JANNES, GEERT; HABERHAUSEN, GERD; EMRICH, THOMAS; VERDOODT, LIA
To: INNOGENETICS N.V.; ROCHE DIAGNOSTICS GMBH
Reel/Frame 033756/0785 →
CHANGE OF NAME Recorded Sep 17, 2014
From: INNOGENETICS N.V.
To: FUJIREBIO EUROPE N.V.
Reel/Frame 033763/0369 →
Priority Claims (1)
EP 02447247 · Dec 6, 2002 · regional
Continuity (2)
Continuation 10537787
Related Publication 20080199878A1 · Aug 21, 2008